5-Ethyl-10-methoxy dibenzazepine(15882-79-8)
- Name: 5-Ethyl-10-methoxy dibenzazepine
- Synonyms:5-Ethyl-10-methoxy dibenzazepine;15882-79-8;5-Ethyl-10-methoxy iminostilbene;UNII-4E3E494GMI;Oxcarbazepine impurity G [EP];4E3E494GMI;11-ethyl-5-methoxybenzo[b][1]benzazepine;5-Ethyl-10-methoxy-5H-dibenzo(b,f)azepine;5H-Dibenz(b,f)azepine, 5-ethyl-10-methoxy-;5-Ethyl-10-methoxy-5H-dibenz[b,f]azepine;5-Ethyl-10-methoxy-5H-dibenzo[b,f]azepine;Oxcarbazepine EP Impurity G;OXCARBAZEPINE IMPURITY G [EP IMPURITY];Q27259476
- Molecular Formula:C17H17NO
- Molecular Weight:251.32
- CAS Registry Number:15882-79-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.15882-79-8 Oxcarbazepine EP Impurity G
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurities, for drug standards,for drug research and development
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.15882-79-8 5-Ethyl-10-methoxy dibenzazepine
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:5-Ethyl-10-methoxy dibenzazepine
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.15882-79-8 5-Ethyl-10-methoxy dibenzazepine
Assay:> 95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 83966-98-7/1-(2-Bromo-2-deoxy-beta-D-arabinofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione
- 1311254-69-9/4-[3-(Trifluoromethyl)phenyl]oxan-4-ylmethanamine hydrochloride
- 1000577-64-9/6-Amino-3-chloro-2-fluorobenzonitrile
- 1171919-37-1/2,4,6-Trichlorophenyl 4-fluorobenzenesulfonate
- 210230-43-6/N-Trimethyl-N-hexylammonium bis(trifluoromethanesulfonyl)imide
- 1568026-19-6/(3S)-1-(2,2-difluoroethyl)pyrrolidin-3-ol
- 1234710-01-0/2-(azetidin-3-yl)-1H-imidazole
- 72366-66-6/4'-Ethyl[1,1'-biphenyl]-4-carboxamide
- 884504-65-8/1-(Hydroxyimino)-2-naphthyloxyethylamine
- 1245645-03-7/[5-(5-Carboxy-2-methoxyphenoxy)pentyl]propanedioic acid
- 877964-38-0/4-chloro-1-methyl-1H-pyrrole-2-carboxylic acid
- 1246818-83-6/Tebuconazole-d9
- 1367940-06-4/5-Aminoisoxazole-3-carboxylic acid
- 1119450-13-3/[9-methoxy-2-(3-methoxyphenyl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl]acetic acid
- 1333233-46-7/Dithiodesmethylcarbodenafil
- 1416440-61-3/7-Bromo-3-iodoquinoline
- 874816-14-5/9,9-Dioctyl-2,7-bis(3,5-dimethylphenyl)-9H-fluorene
- 1214329-65-3/2-(Difluoromethoxy)-5-fluoroaniline
- 139742-20-4/Methylsyringin
- 15882-79-8/5-Ethyl-10-methoxy dibenzazepine
- 1330583-62-4/Ethyl 6-bromo-2-chloro-1,8-naphthyridine-3-carboxylate
- 866761-71-9/Acetic acid, 2-((4R)-1-((1S)-2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4-mercapto-3-piperidinylidene)-, (2Z)-
- 1378466-25-1/2-((2RS)-2-Aminobut-3-enyl)propanedioic acid
- 1624272-57-6/(S)-Methyl 2-amino-3-(benzhydrylthio)propanoate
- 1262002-40-3/2-Chloro-5-(3,5-dimethyl-1,2-oxazol-4-yl)phenol
- 1350800-76-8/Saxagliptin metabolite D1
- 951885-73-7/2-Chloro-3-(3-methyl-2-thienyl)-1-propene
- 2032409-51-9/(4-((2-Hydroxyethyl)thio)phenyl)boronic acid
- 1363380-50-0/1-Methyl-1,3,7-triazaspiro[4.5]decan-4-one
- 1393442-35-7/Ethyl 2-fluoro-4-(4-formylphenyl)benzoate